SPG4 and Dementia: Expanding the Clinical Spectrum

Read full text Summarise with VIRAT
Authors: Emanuele Panza, Arun Meyyazhagan, Eliseo Picchi, Gustavo da Cunha Ribas, Ingrid Faber, Ryosuke Miyamoto, Preethi Basavaraju, Paolo Eusebi, Haripriya Kuchi Bhotla, Mario Stasi, Fabrizio Gaudiello, Francesco Patti
+8 more Filippo Maria Santorelli, Marcondes Cavalcante França, José Luiz Pedroso, Orlando Graziani Póvoas Barsottini, Hélio Afonso Ghizoni Teive, Peter St George‐Hyslop, Toshitaka Kawarai, Antonio Orlacchio
Cited by: 0
References: 59

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVE: Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing. We examined the clinical, pathological, and genetic spectrum of the SPG4/SPAST gene in patients with HSP. METHODS: The study involved 726 HSP patients recruited from Italy, Brazil, and Japan between 2001 and 2025, with analysis conducted in collaborative centers. SPG4/SPAST variants were identified using direct and next-generation sequencing. The pathogenicity of novel variants was confirmed through familial segregation and in silico analysis. RESULTS: Clinical and epidemiological differences were observed across populations, particularly in phenotype, age at onset, and disability, expanding the SPG4 clinical spectrum. Genetic analysis identified 52 pathogenic SPG4/SPAST mutations in 284 patients, including four novel variants. Several mutations were population-specific, and a possible founder effect was suggested for a recurrent variant in Italy. Dementia occurred in 44 HSP-SPG4 patients and was neuropathologically confirmed in four unrelated autopsied cases from four families comprising 28 individuals; atypical pathological features were observed in all four autopsied cases. Additionally, 18 patients with SPG4/SPAST mutations presented with thin corpus callosum and intellectual disability. INTERPRETATION: In this study, we investigated pathogenic SPG4/SPAST variants in an international cohort of HSP patients from three continents. Our findings expand the clinical spectrum of HSP-SPG4, identifying a new type complicated by an atypical pathological form of dementia. Careful assessment of genotype-phenotype relationships offers insights into patient counseling and future research planning.

Fields of Study & Subjects

Hereditary Neurological Disorders Genetic Neurodegenerative Diseases Cerebrovascular and genetic disorders

Publication details

Journal / source
Annals of Clinical and Translational Neurology
Volume
13
Issue
10
Pages
2002–2016
Publication date
26 March 2026
Language
EN